Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05819996 · ClinicalTrials.gov registry record · NA
Addressing Tetrachloroethylene Exposure in an Impacted Community
A NA study of Cancer and Vapors; Inhalation, sponsored by Purdue University.
- Recruiting
- Registry status
- NA
- Development phase
- 510
- Enrollment target
- 1
- Study location
NCT05819996: Recruiting NA study of Cancer and Vapors; Inhalation, sponsored by Purdue University.
NCT05819996 is a NA study of Cancer and Vapors; Inhalation that is actively recruiting participants, run by Purdue University. The registered enrollment target is 510 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05819996, a NA study of Cancer and Vapors; Inhalation, is actively recruiting participants, sponsored by Purdue University.
- RECRUITING
- Registry status
- NA
- Development phase
- 510 participants
- Enrollment target
- 1
- Study location
Study Summary
Groundwater in Martinsville, IN, is contaminated by volatile organic compounds (VOCs), tetrachloroethylene (PCE) and trichloroethylene (TCE). Indoor air in some residential and commercial buildings is also contaminated with PCE and TCE. This study is being conducted to better understand the impact of low-level exposures to these compounds on community members' health. Data collected in this study will be used to help the community identify a course of action.
Primary Outcome
This measure is based on the differences between the percentage of "Yes" responses to a close-ended, not scaled question at 3 different time points, administered via repeated surveys to the same sample of respondents. Are participants concerned about environmental chemical contamination in Martinsville? Yes / Somewhat / No / Refuse 1a. Changes in concerns about environmental chemical contamination in Martinsville from Year 1 to Year 3. This is based on the differences in percentage of yes resp
Conditions Studied
Interventions
- BEHAVIORAL Environmental educational campaign
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2023-02-17 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
What NCT05819996 shows while recruiting
NCT05819996 is an interventional study that assigns participants to a tested intervention. The registered 510 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Environmental educational campaign is the first listed.
NCT05819996 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05819996 about?
NCT05819996 is a clinical study titled "Addressing Tetrachloroethylene Exposure in an Impacted Community". Groundwater in Martinsville, IN, is contaminated by volatile organic compounds (VOCs), tetrachloroethylene (PCE) and trichloroethylene (TCE). Indoor air in some residential and commercial buildings is also contaminated with PCE and TCE. This study is being conducted to better understand the impact o...
What is the current status of trial NCT05819996?
This trial is currently recruiting. It is a NA study. The enrollment target is 510 participants. The study started on 2023-02-17. Estimated completion is 2028-05-31.
What conditions does trial NCT05819996 study?
This clinical trial studies the following conditions: Cancer, Vapors; Inhalation, Volatile Organic Compounds.
What interventions are being tested in trial NCT05819996?
The interventions under investigation include: Environmental educational campaign (BEHAVIORAL).
Who is sponsoring clinical trial NCT05819996?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05819996 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05819996's enrollment target sits among peer trials
510 120th of 615 higher than 496 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI